Abstract
Background Ontario, being one of Canada’s largest provinces, has been central to the high incidence of human Mpox. Research is scarce on how socio-environmental factors influence Mpox incidences. This study seeks to explore potential geographical correlations and the relationship between indicators of social marginalization and Mpox incidence rate in Ontario.
Methodology We used surveillance data on confirmed human Mpox cases from May 1, 2022, to March 31, 2024, extracted from the Public Health Ontario website for this study. Spatial autocorrelation of Mpox incidence was investigated using spatial methods including Moran’s Index, Getis–Ord Gi*statistic, and spatial scan statistic. Following this, we adopted a generalized Poisson regression (GPR) model to estimate the incidence rate ratios (IRRs) based on the association between Ontario PHU-level marginalization and Mpox incidence, while adjusting for age and sex. The goodness-of-fit of the models was assessed using the Akaike Information Criterion (AIC), Akaike’s Information Criterion corrected (AICc), and the Bayesian Information Criterion (BIC).
Results Spatial scan statistics, LISA, and Getis-Ord Gi*statistics revealed similar results for PHUs with the highest rates of Mpox in Ontario. Our study detected statistically significantly higher Mpox cases in Toronto, Ottawa, Peterborough, Kingston, Peel, Wellington-Dufferin-Guelph, Middlesex-London, Halton region, Brant County, Hamilton, and Haldimand-Norfolk PHUs (p − value < 0.05). Higher rates of Mpox infection in Ontario were associated with ethnic concentration (racialized, migrants or visible minority) (RR = 9.478; 95% CI = 1.621 − 2.876), and male gender (RR = 5.150; 95% CI = 1.159 − 2.119) and residential instability (RR = 14.112; 95% CI = 1.887, 3.407).
Conclusion We identified major Mpox hotspots in Toronto. According to our model results, the high incidence rate may be influenced by the greater population of internal migrant population and younger individuals. Based on these insights, we recommend targeted interventions in the high-risk neighborhoods. Efforts to improve Mpox diagnosis and promote health equity among socioeconomically vulnerable populations, including racial and ethnic minorities, should be implemented.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Canadian Institute for Health Research (CIHR) under the Mpox and other zoonotic threats Team Grant (FRN. 187246).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Remove one co-author from the list. The co-author has requested me to remove their name due to their recent new job.
Data Availability
The data underlying the results presented in the study are available from the Integrated Public Health Information System (iPHIS) of Public Health Ontario (PHO): https://www.publichealthontarioca/en/Diseases-and-Conditions/Infectious-Diseases/Vector-Borne-Zoonotic-Diseases/mpox, and https://www.12statcangcca/census-recensement/2021/geo/sip-pis/boundary-limites/index2021-engcfm?year=21
https://www.publichealthontario.ca/en/Data-and-Analysis/Health-Equity/Ontario-Marginalization-Index
https://www.12statcangcca/census-recensement/2021/dp-pd/prof/indexcfm?Lang=E